STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual General Meeting on August 28, 2014, the Chairman of the Board has contacted the company’s four largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself, each of whom expressed an interest in participating in the Nomination Committee, and appointed one member (see below) to form Elekta’s Nomination Committee together with the Chairman of the Board.
Nomination Committee members:
· Laurent Leksell, in his capacity as Chairman of the Board of Elekta and representing his own and related parties’ holdings
· Åsa Nisell, appointed by Swedbank Robur funds
· Jens Barnevik, appointed by Didner & Gerge Funds
· Anders Oscarsson, appointed by AMF and AMF Funds
· Ossian Ekdahl, appointed by the First Swedish National Pension Fund
The Nomination Committee will appoint one of its members as Chairman.
The Nomination Committee is tasked ahead of the 2015 Annual General Meeting with preparing proposals pertaining to the number of Board members, Board fees, fees for committee work, the composition of the Board, election of the Chairman of the Board, election of the Chairman of the Annual General Meeting, auditors’ fees and election of auditors as well as guidelines for appointing the Nomination Committee.
Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail at firstname.lastname@example.org or by letter to:
Elekta AB, Nomination Committee
# # #
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 16:00 CET on November 3, 2014.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com